From the Univ Brest, CHU Brest, Médecine Nucléaire, GETBO, UMR1304, Brest, France.
Department of Nuclear Medicine, Maria Hilf Hospital, Mönchengladbach, Germany.
Clin Nucl Med. 2024 Nov 1;49(11):997-1003. doi: 10.1097/RLU.0000000000005396. Epub 2024 Jul 31.
Although ventilation/perfusion (V/Q) scintigraphy is a widely used imaging test, different options are possible for the acquisition and interpretation of the scan. The aim of this study was to assess current practices regarding the use and interpretation of lung scintigraphy in various clinical indications.
An online survey comprising 25 questions was sent to nuclear medicine departments in Australia, Canada, France, Germany, and United States between 2022 and 2023. A single response per department was consolidated.
Four hundred nineteen responses were collected (Australia: 32, Canada: 58, France: 149, Germany: 92, and United States: 88). For acute pulmonary embolism (PE) diagnosis, 82.8% of centers reported using SPECT acquisitions (Australia: 93.3%, Canada: 91.8%, France: 99.2%, Germany: 96.2%, and United States: 32.1%). Among them, SPECT images were combined with a CT scan in 70.5% of centers. A total of 10.6% of centers reported not using ventilation for acute PE diagnosis. SPECT acquisition was used in 97.8% of centers using 99m Tc carbon particles, 97.1% 81m Kr gas, 58.7% 99m Tc-DTPA, and 19.4% 133 Xe gas, respectively. For V/Q SPECT interpretation, the EANM criteria were used in 65.0% of departments. A very wide variety of practices were observed in pregnant women and in COVID-19 patients. SPECT acquisition was widely used in the follow-up of PE and for the screening of chronic thromboembolic pulmonary hypertension (>90% of centers), with inconsistency regarding the interpretation of matched perfusion defects in this setting.
This survey shows the strong adoption of SPECT in the various clinical indications of lung scintigraphy, except in the United States, where planar imaging is still mostly used. The survey also shows variability in interpretation criteria both for PE diagnosis and screening for chronic thromboembolic pulmonary hypertension, highlighting the need for further standardizations of practices.
尽管通气/灌注(V/Q)闪烁显像术是一种广泛使用的影像学检查方法,但在采集和解释扫描方面有多种选择。本研究旨在评估不同临床适应证下肺闪烁显像术的使用和解释的当前实践情况。
在 2022 年至 2023 年期间,向澳大利亚、加拿大、法国、德国和美国的核医学科发送了一份包含 25 个问题的在线调查。每个科室只合并了一次回复。
共收集了 419 份回复(澳大利亚:32 份,加拿大:58 份,法国:149 份,德国:92 份,美国:88 份)。对于急性肺栓塞(PE)的诊断,82.8%的中心报告使用 SPECT 采集(澳大利亚:93.3%,加拿大:91.8%,法国:99.2%,德国:96.2%,美国:32.1%)。其中,70.5%的中心将 SPECT 图像与 CT 扫描相结合。总共 10.6%的中心报告不使用通气来诊断急性 PE。97.8%的中心使用 99mTc 碳颗粒、97.1%的中心使用 81mKr 气体、58.7%的中心使用 99mTc-DTPA 和 19.4%的中心使用 133Xe 气体进行 SPECT 采集。对于 V/Q SPECT 解释,EANM 标准在 65.0%的科室中使用。在孕妇和 COVID-19 患者中观察到各种各样的实践。SPECT 采集在 PE 的随访和慢性血栓栓塞性肺动脉高压的筛查中广泛应用(>90%的中心),但在这种情况下,对匹配的灌注缺损的解释标准不一致。
本调查显示,SPECT 在肺闪烁显像术的各种临床适应证中得到了广泛应用,除了美国,那里仍主要使用平面成像。调查还显示,PE 诊断和慢性血栓栓塞性肺动脉高压筛查的解释标准存在差异,突出了进一步规范实践的必要性。